SAMC
CNCE

Shinko Asset Management Company’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Shinko Asset Management Company’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$366K Sell
36,163
-19,771
-35% -$216K ﹤0.01% 267
2016
Q2 		$628K Hold
55,934
– – ﹤0.01% 228
2016
Q1 		$764K Hold
55,934
– – 0.01% 199
2015
Q4 		$1.06M Hold
55,934
– – 0.01% 191
2015
Q3 		$1.05M Buy
+55,934
New +$951K 0.01% 191

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Shinko Asset Management Company's CNCE Position: Q3 2016 in Review

Shinko Asset Management Company reduced its Concert Pharmaceuticals, Inc. (CNCE) stake by 35% in Q3 2016, selling an estimated $216K and leaving 36,163 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Shinko Asset Management Company first reported a position in CNCE in Q3 2015 and has held it in 5 quarters since. The position peaked at $1.06M in Q4 2015. 94 funds tracked by Wall St. Rank hold CNCE as of Q3 2016.

  • Shinko Asset Management Company held 36,163 shares of Concert Pharmaceuticals, Inc. worth $366K as of Q3 2016.
  • Shinko Asset Management Company sold 19,771 Concert Pharmaceuticals, Inc. shares in Q3 2016, an estimated $216K.
  • Concert Pharmaceuticals, Inc. made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #267 holding.
  • Shinko Asset Management Company first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and has held it in 5 quarters since.
  • Shinko Asset Management Company's Concert Pharmaceuticals, Inc. position peaked at $1.06M in Q4 2015.
  • 94 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.